Kymera Therapeutics is Named one of the FierceBiotech's Fierce 15 Companies of 2019

/PRNewswire/ -- Kymera Therapeutics Inc., a biotechnology company advancing the field of targeted protein degradation to create next generation medicines

SEC Filing Kymera Therapeutics, Inc.

The Top Line': Fierce Biotech's Fierce 15, plus a deep dive into

SEC Filing — Vigil Neuroscience, Inc

Chris De Savi on LinkedIn: Kymera Therapeutics is Named one of

Fierce Biotech names MOMA Therapeutics as one of its “Fierce 15

Kymera Therapeutics Receives FDA Orphan Drug Designation for KT

Fierce Biotech names Imvax Inc. as one of its Fierce 15 Biotech

S-1

FierceBiotech names Frontier Medicines one of its Fierce 15

Board of Directors

FierceBiotech's 2019 Fierce 15